TOLAK CREAM Canadá - inglés - Health Canada

tolak cream

hill dermaceuticals inc - fluorouracil (fluorouracil sodium) - cream - 4% - fluorouracil (fluorouracil sodium) 4% - misc. skin and mucous membrane agents

Efudix 5% w/w Cream Malta - inglés - Medicines Authority

efudix 5% w/w cream

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - fluorouracil - cream - fluorouracil 5 % (w/w) - antineoplastic agents

AZADINE POWDER FOR SUSPENSION FOR INJECTION 100MGVIAL Singapur - inglés - HSA (Health Sciences Authority)

azadine powder for suspension for injection 100mgvial

accord healthcare private limited - azacitidine - injection, powder, lyophilized, for suspension - azacitidine 100 mg

LONSURF 15 MG6.14 MG Israel - inglés - Ministry of Health

lonsurf 15 mg6.14 mg

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

LONSURF 15 MG6.14 MG Israel - inglés - Ministry of Health

lonsurf 15 mg6.14 mg

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 6.14 mg; trifluridine 15 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

LONSURF 20 MG8.19 MG Israel - inglés - Ministry of Health

lonsurf 20 mg8.19 mg

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

LONSURF 20 MG8.19MG Israel - inglés - Ministry of Health

lonsurf 20 mg8.19mg

medison pharma ltd - tipiracil as hydrochloride; trifluridine - film coated tablets - tipiracil as hydrochloride 8.19 mg; trifluridine 20 mg - trifluridine, combinations - colorectal cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti-egfr agents.gastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Azacitidine Clonmel 25 mg/ml powder for suspension for injection Irlanda - inglés - HPRA (Health Products Regulatory Authority)

azacitidine clonmel 25 mg/ml powder for suspension for injection

clonmel healthcare ltd - azacitidine - powder for suspension for injection - 25 milligram(s)/millilitre - azacitidine

Azacitidine Rowex 25 mg/ml Powder for suspension for injection Irlanda - inglés - HPRA (Health Products Regulatory Authority)

azacitidine rowex 25 mg/ml powder for suspension for injection

rowex ltd - azacitidine - powder for suspension for injection - 25 milligram(s)/millilitre - azacitidine